Detalhe da pesquisa
1.
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.
Lancet
; 393(10191): 2599-2612, 2019 06 29.
Artigo
Inglês
| MEDLINE | ID: mdl-31178152
2.
Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial.
Mod Pathol
; 30(8): 1069-1077, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28548129
3.
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial.
Value Health
; 20(10): 1311-1318, 2017 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29241890
4.
Trastuzumab-associated cardiac events in the Persephone trial.
Br J Cancer
; 115(12): 1462-1470, 2016 Dec 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27875516
5.
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 16(6): 656-66, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25975632
6.
Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial.
Lancet Oncol
; 15(2): 201-12, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24360787
7.
The International Core Literature Consensus (ICLC): an alternative curriculum for Oncologists.
J Cancer Educ
; 26(3): 420-6, 2011 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21644006
8.
BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer.
Mol Cancer
; 9: 111, 2010 May 19.
Artigo
Inglês
| MEDLINE | ID: mdl-20482821
9.
Definition of Tumor Bed Boost in Oncoplastic Breast Surgery: An Understanding and Approach.
Clin Breast Cancer
; 20(4): e510-e515, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32284305
10.
Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT.
Health Technol Assess
; 24(40): 1-190, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32880572
11.
The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains.
Trends Biochem Sci
; 28(2): 69-74, 2003 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-12575993
12.
Aiming for a holistic integrated service for men diagnosed with prostate cancer - Definitions of standards and skill sets for nurses and allied healthcare professionals.
Eur J Oncol Nurs
; 29: 31-38, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28720263
13.
Crystal structure of the ENT domain of human EMSY.
J Mol Biol
; 350(5): 964-73, 2005 Jul 29.
Artigo
Inglês
| MEDLINE | ID: mdl-15978617
14.
OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer.
Health Technol Assess
; 20(10): xxiii-xxix, 1-201, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26867046
15.
Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others.
J Natl Cancer Inst
; 108(9)2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27130929
16.
Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome.
Clin Cancer Res
; 10(17): 5785-91, 2004 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15355907
17.
Corrigendum to "Aiming for a holistic integrated service for men diagnosed with prostate cancer - Definitions of standards and skill sets for nurses and allied healthcare professionals" [Eur. J. Oncol. Nurs. 29 (2017) 31-38].
Eur J Oncol Nurs
; 30: 59, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29031314
18.
Nerve growth factor/nuclear factor-kappaB pathway as a therapeutic target in breast cancer.
J Cancer Res Clin Oncol
; 135(2): 211-6, 2009 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-18716795
19.
A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer.
Neoplasia
; 10(6): 542-8, 2008 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-18516291
20.
Binding of EMSY to HP1beta: implications for recruitment of HP1beta and BS69.
EMBO Rep
; 6(7): 675-80, 2005 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-15947784